Modified extracellular vesicles that specifically target kidneys and methods of preparation and applications thereof
AssigneeZhongnan Hospital of Wuhan University
InventorsYiming LI, Zhiyong PENG, Jinmeng SUO
Life of this patent
Estimating the term…
Loading patent…
AssigneeZhongnan Hospital of Wuhan University
InventorsYiming LI, Zhiyong PENG, Jinmeng SUO
Estimating the term…
The present invention discloses a method for the preparation and application of modified extracellular vesicles specifically targeted to the kidneys. These modified extracellular vesicles are derived from fibroblastic reticular cells in the mesentery tissue and express anti-inflammatory proteins after being modified with anchor peptides. By combining the extracellular vesicles secreted from fibroblastic reticular cells in the mesentery tissue with anchor peptides, the present invention ensures the effective targeting of the exosomes to the kidneys. Additionally, through genetic engineering of fibroblastic reticular cells, the exosomes secreted by these cells can carry the target molecule, anti-inflammatory protein CD5L, achieving precise targeted therapy for the kidneys. This innovative treatment strategy holds promising potential for the treatment of sepsis-associated acute kidney injury, bringing positive impacts to patients' health.
A modified extracellular vesicle that specifically target kidneys, characterized in that the modified extracellular vesicle that specifically target the kidneys is obtained by co-incubating extracellular vesicles secreted by reticular fibroblasts from mesenteric tissue expressing CD5 antigen-like proteins with anchoring peptides.
Dependencies are inferred from the claim text.